ACTRN12616000710426招募中3 期
The effects of a exenatide extended release ( Bydureon) on appetite and gastric emptying in Prader-Willi syndrome
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 65 Years（—）
- 性别
- All
入选标准
- •PWS group: genetic diagnosis of PWS
- •BMI-matched group( instead of Obese group): healthy; any obesity-related comorbidities must be treated, BMI -matched to PWS cohort.
- •Lean group: health; BMI <25
排除标准
- •PWS: Uncontrolled access to food in current living situation; history of psychological illness within previous 12 months; pregnant women.
- •Obese: unstable body weight within previous 3 months (+/- 2kg or greater); pregnant women.
- •Lean: unstable body weight within previous 3 months (+/- 2kg or greater); pregnant women.
研究者
相似试验
已完成
不适用
Effects of exenatide extended-release in patients with type 2 diabetes mellitustype 2 diabetes mellitusJPRN-UMIN000018740Tokyo Women's Medical University100
进行中（未招募）
不适用
Eficacia de exenatida de liberación prolongada administrada una vez a la semana e insulina glargina administrada una vez al día en pacientes con diabetes tipo 2 tratados con metformina en monoterapia o en combinación con sulfonilurea o tiazolidindiona Efficacy of once weekly exenatide long acting release and once daily insulin glargine in patients with Type 2 diabetes treated with metformin alone or in combination with sulphonylurea or thiazolidinedione. - GWBREUCTR2007-002957-22-ESilly S.A.456
进行中（未招募）
不适用
A Study to Assess the Effect of Exenatide Treatment on Mean 24-hour Heart Rate in Patients with Type 2 Diabetes - GWCDEUCTR2007-002691-33-NLEli Lilly and Company Ltd50
进行中（未招募）
不适用
Effect of additional treatment with exenatide in patients with an acute myocardial infarction: the EXAMI trial)EUCTR2009-014272-21-NLVU University Medical Center40
已完成
3 期
A Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly in Subjects With Type 2 Diabetes Mellitus (DURATION-5)Type 2 Diabetes MellitusNCT00877890AstraZeneca254